Current stock page

Financial Data

ICLR Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Diagnostics & ResearchScore data as of Sep 4, 2026

ICLR

Financial Data
ICON Public Limited Company
Healthcare· Medical - Diagnostics & Research
AIQ Score
NeutralAIQ Edge 4/10
Low Priority
In Line With Peers
Score data as of Sep 4, 2026
Last price
$164.85
+$1.27 (+0.78%)
Latest market quote
Momentum39
Value67
Quality38
Risk Resilience51
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 6, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$2.06B$2.03B$2.11B$2.04B$2.02B$2B$2.04B$2.03B
Gross Profit$388.53M$477.93M$480.74M$455.95M$561.6M$558.65M$599.37M$591.41M
Operating Income
Net Income$72.58M$104.75M$149.19M$2.36M$182.97M$154.15M$260M$197.13M
EPS$0.94$1.37$1.95$0.03$2.31$1.91$3.18$2.38
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$277.53M$167.01M$767.97M$408.51M$162.19M$268.24M$338.31M$402.67M
Capital Expenditure-$42.18M-$30.77M-$145.31M-$56.62M-$34.64M-$28.91M-$61.29M-$43.33M
Free Cash Flow$235.34M$136.24M$622.66M$351.89M$127.55M$239.33M$277.03M$359.34M
Net Cash Provided By Operating Activities$277.53M$167.01M$767.97M$408.51M$162.19M$268.24M$338.31M$402.67M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$16.4B$16.32B$16.27B$16.51B$16.6B$16.72B$16.88B$17.21B
Total Debt$3.49B$3.51B$3.56B$3.57B$3.55B$3.56B$3.6B$3.58B
Cash And Cash Equivalents
Total Liabilities$7.02B$7.02B$7.08B$7.17B$7.05B$7.22B$7.35B$7.44B
Total Stockholders Equity$9.38B$9.3B$9.19B$9.33B$9.56B$9.5B$9.52B$9.77B
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio46.220.1923.361,437.4115.7523.2116.4930.18
P/B ratio1.420.911.551.451.211.511.82.43
P/S ratio6.474.176.766.635.717.158.411.72
Debt To Equity0.370.380.390.380.370.370.380.37
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio1.420.911.551.451.211.511.82.43
P/S ratio6.474.176.766.635.717.158.411.72
Return On Equity0.77%1.13%1.62%0.03%1.91%1.62%2.73%2.02%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
37.62
multipleSep 4, 2026
Pb
1.32
multipleSep 4, 2026
Revenue Growth Yoy
1.45
percentSep 4, 2026
EPS Growth Yoy
-31.39
percentSep 4, 2026
Gross Margin
21.85
percentSep 4, 2026
Operating Margin
10.15
percentSep 4, 2026
ROE
3.54
percentSep 4, 2026
ROIC
4.8
percentSep 4, 2026
Debt To Equity
0.37
ratioSep 4, 2026
FCF Yield
10.89
percentSep 4, 2026
Technical indicators
Close
164.85
priceSep 4, 2026
Volume
796,396
volumeSep 4, 2026
Rsi14
43.19
indexSep 4, 2026
MACD
-0.42
indexSep 4, 2026
MACD Signal
0.58
indexSep 4, 2026
MACD Histogram
-1
indexSep 4, 2026
Adx14
13.8
indexSep 4, 2026
Sma50
168
priceSep 4, 2026
Sma200
147.41
priceSep 4, 2026
Atr14
6.56
priceSep 4, 2026
Historical Volatility
0.3
percentSep 4, 2026
Volume Ma20
548,789.3
volumeSep 4, 2026
Risk measures
Resilience Score
51
score_0_100Sep 4, 2026
Beta
1.2
ratioSep 4, 2026
Volatility Annual
67.34
percentSep 4, 2026
Max Drawdown
-60.54
percentSep 4, 2026
Sharpe Ratio
0.22
ratioSep 4, 2026
Var95
-4.74
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

ICLR Financial Data FAQ

What is ICON Public Limited Company's revenue?

ICON Public Limited Company's revenue is one of the core financial data points for ICLR. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is ICON Public Limited Company's revenue growing?

Revenue growth shows whether ICON Public Limited Company is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is ICLR's EPS?

ICLR's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is ICON Public Limited Company's net income?

ICON Public Limited Company's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does ICON Public Limited Company generate?

Free cash flow shows how much cash ICON Public Limited Company generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does ICON Public Limited Company have?

Cash and debt help frame ICLR's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.